Artelo Biosciences (ARTL) Other Operating Expenses (2014 - 2026)
Artelo Biosciences (ARTL) reported Other Operating Expenses of $773,000 for Q1 2026, down 44.1% from $1.38 million a year earlier and down 13.4% from the prior quarter.
Powered by 
Analysis
Artelo Biosciences (ARTL) Other Operating Expenses (2014 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Artelo Biosciences' Other Operating Expenses came in at $4.81 million, down 18.0% year-over-year; for FY2025, it came in at $5.42 million, down 9.5% from FY2024.
- Other Operating Expenses has a five-year compound annual growth rate of 13.4% (FY2020 to FY2025).
- By year, Other Operating Expenses came in at $5.99 million in FY2024 (+5.2%), $5.7 million in FY2023 (+31.7%), $4.32 million in FY2022 (+14.3%) and $3.78 million in FY2021.
- The Q1 2026 figure ranks as the lowest quarterly Other Operating Expenses since Q3 2024.
- Year over year, Other Operating Expenses gained in four of the last eight quarters, with growth averaging 31.0%.
- The high point for year-over-year Other Operating Expenses in five years was Q3 2025 (growth of 292.3%); the low point was Q3 2024 (a decline of 79.5%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $893,000 (Q4 2025), $1.28 million (Q3 2025) and $1.87 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Artelo Biosciences | 49.32 Mn | 32.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 294,000.00 |
| Dec 31, 2025 | 310,000.00 |
| Sep 30, 2025 | 332,000.00 |
| Jun 30, 2025 | 249,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Dec 31, 2024 | 373,000.00 |
| Sep 30, 2024 | 326,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 309,000.00 |
| May 31, 2021 | 226,042.00 |
| Feb 28, 2021 | 197,599.00 |
| Nov 30, 2020 | -60.00 |
| Aug 31, 2020 | 192,739.00 |
| May 31, 2020 | 303,400.00 |
| Feb 29, 2020 | 215,382.00 |
| Nov 30, 2019 | 266,227.00 |
| Aug 31, 2019 | 433,418.00 |
| May 31, 2019 | 354,038.00 |
| Feb 28, 2019 | 209,946.00 |
| Nov 30, 2018 | 167,293.00 |
API Access
Artelo Biosciences Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();